<?xml version="1.0" encoding="gb2312" ?>
<rss version="2.0">
<channel>
<title>bio-equip.cn RSS feed</title>
<link>http://www.bio-equip.cn</link>
<language>zh-cn</language>
<copyright>An RSS feed for bio-equip.cn </copyright>
<item>
<title><![CDATA[Olympus Launches 4K LCD Monitors to Enhance Clarity in Endoscopic Diagnosis and Therapy]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10713</link>
<description><![CDATA[<div style="text-align: center;"><span style="font-family:arial,helvetica,sans-serif"><strong>Supporting Accurate Diagnosis for Better Patient Outcomes<br />
<br />
<img alt="" src="/imgproduct/2026/2026062553446300.jpg" style="height:270px; width:508px" /></strong></span></div>

<div style="text-align: center;"><em><span style="font-family:arial,helvetica,sans-serif">&nbsp;(From Left) OEV-271MUH/ OEV-321MUH / OEV-431MUH</span></em></div>
<span style="font-family:arial,helvetica,sans-serif"<br /><br />]]></description>
<pubDate>Thu, 25 Jun 2026 14:52:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10712</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif">Agilent Technologies Inc. (NYSE: A) today announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the company&rsquo;s products, operations, and customer workflows.<br />
<br />
&ldquo;AI is a top priority, and this partnership reflects both our ambition and our execution commitment &mdash; to build the enduring capability, operating model, and capacity requir<br /><br />]]></description>
<pubDate>Thu, 25 Jun 2026 14:43:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Agilent and Sound Analytics Collaborate to Advance LC/MS Workflows for Drug Metabolism Research]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10711</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif">Agilent Technologies Inc. and Sound Analytics, LLC, today announced a collaboration to deliver an integrated liquid chromatography&ndash;triple quadrupole mass spectrometry (LC/MS) workflow designed to support drug metabolism and pharmacokinetics (DMPK) laboratories in biopharma and pharmaceutical research.&nbsp;<br />
<br />
The joint solution combines Agilent&rsquo;s 1290 Infinity III Liquid Chromatography system and 6495D triple quadrupol<br /><br />]]></description>
<pubDate>Thu, 25 Jun 2026 14:31:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Waters BD BACTEC FXI Culture System has Received U.S. Food and Drug Administration (FDA) 510(k) Clearance]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10710</link>
<description><![CDATA[<div style="text-align: center;"><strong>Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics</strong></div>
<br />
&bull;<span style="font-family:arial,helvetica,sans-serif">&nbsp;FDA 510(k)-cleared BD BACTEC&trade; FXI Culture System now available to U.S. market, enabling broader access to confident bloodstream infection diagnostics.</span><br />
&bull;<span style="font-family:arial,helvetica,sans-serif">&nbsp;Ac<br /><br />]]></description>
<pubDate>Thu, 25 Jun 2026 14:20:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Waters Launches Industry-First Reversed-Phase Bioseparation Columns]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10709</link>
<description><![CDATA[<div style="text-align: center;"><span style="font-family:arial,helvetica,sans-serif"><strong>Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis</strong></span></div>
<span style="font-family:arial,helvetica,sans-serif">&nbsp;<br />
&bull;Faster run times for&nbsp;GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlen<br /><br />]]></description>
<pubDate>Thu, 25 Jun 2026 14:05:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10708</link>
<description><![CDATA[<strong>&bull;<span style="font-family:arial,helvetica,sans-serif">&nbsp;Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis</span><br />
&bull;<span style="font-family:arial,helvetica,sans-serif">&nbsp;Integrates&nbsp;heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway.</span><br />
&bull;</strong><span style="font-f<br /><br />]]></description>
<pubDate>Thu, 25 Jun 2026 14:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Functional Antibodies: Unlocking Unlimited Potential in Biomedical Research]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10707</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif"><strong>1. Concept of Functional Antibodies and Core Classification</strong><br />
Functional antibodies are specialized immunoglobulins that not only bind specific antigens but also actively modulate target protein function&mdash;distinguishing them from traditional detection-only antibodies. They intervene in biological processes via neutralization, blocking, or activation, serving as key tools in basic research, drug development, and clini<br /><br />]]></description>
<pubDate>Thu, 25 Jun 2026 10:58:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Monoclonal Antibodies: Reshaping the Landscape of Modern Disease Treatment]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10706</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif"><strong>1. Concept of Monoclonal Antibodies and Core Characteristics</strong><br />
Monoclonal antibodies (mAbs) are highly homogeneous immunoglobulin molecules produced by a single B cell clone, specifically targeting a single antigenic epitope. Their classic &quot;Y&quot;-shaped structure consists of two identical heavy chains and two identical light chains, linked by disulfide bonds and non-covalent interactions. Each chain includes a cons<br /><br />]]></description>
<pubDate>Thu, 25 Jun 2026 10:09:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Merck Announces Hiba Therapeutics as Winner of 2026 North American Advance Biotech Grant]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10705</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif"><strong>&bull;Hiba Therapeutics&rsquo; targeted biologics platform aims to address key solid tumor treatment challenges, while limiting systemic toxicity<br />
&bull;Grant provides access to Merck&rsquo;s technologies, process development expertise and regulatory support to help advance Hiba&rsquo;s TROIKA platform<br />
&bull;Merck has awarded more than 40 startups globally through the Advance Biotech Grant program since 2014</strong><br /><br /><br />]]></description>
<pubDate>Thu, 25 Jun 2026 10:01:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[BioMed X Launches Global Call for Research Proposals in Neural Circuit Regulation of Immune Function]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10704</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif"><strong>&bull;&nbsp;New initiative supported by Biogen seeks bold ideas at the intersection of neuroscience and immunology to advance understanding of autoimmune diseases.<br />
&nbsp;</strong><br />
NEW HAVEN, CT, USA, June 23, 2026 /&nbsp;<a href="https://www.biotechnewswire.ai/">Biotech Newswire</a>&nbsp;/ --&nbsp;<a href="http://www.biotechnewswire.ai/PRT/link.php?click=2809-2-39281-FE220F775CD1C5CE1A1B9B9601C08AE6512572A40000">BioMed&en<br /><br />]]></description>
<pubDate>Tue, 23 Jun 2026 15:49:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Single Use Support Launches Next-Generation Controlled-Rate Blast Freezer]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10703</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif">&bull;&nbsp;Single Use Support introduces the advanced RoSS.BLST, a blast freezing and thawing platform designed to deliver maximum process consistency and product quality for high-value biologics. With enhanced performance, increased capacity, and recipe-driven freezing protocols down to -80&deg;C, the system sets a new benchmark for reliable, scalable freeze-thaw processes across all single-use bioprocessing container formats.</span>
<div s<br /><br />]]></description>
<pubDate>Tue, 23 Jun 2026 10:31:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[CMS: Class 1 Innovative Drug Silevimig Injection Approved in China]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10702</link>
<description><![CDATA[<div style="text-align: center;"><span style="font-family:arial,helvetica,sans-serif"><strong>CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World&#39;s First Bispecific Antibody for Passive Immunization Against Rabies</strong></span></div>
<br />
<span style="font-family:arial,helvetica,sans-serif">SHENZHEN, June 22, 2026 - (ACN Newswire)&nbsp;-&nbsp;China Medical System Holdings Limited (867.HK/8A8.SG) (&ldquo;CMS&rdquo;, or the &ldquo;Group&rdquo;) is pleas<br /><br />]]></description>
<pubDate>Tue, 23 Jun 2026 10:12:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Can CD366 Become the Next Key Target in Cancer Immunotherapy?]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10701</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif"><strong>1. Concept of CD366 and Its Role in Cancer Immunity</strong><br />
CD366 (TIM-3) is an emerging negative immune checkpoint molecule, belonging to the TIM family of type I transmembrane glycoproteins. Located on human chromosome 5q33.2, it features an immunoglobulin-like domain, mucin-like region, transmembrane domain, and intracellular tyrosine phosphorylation sites. Expressed on CD4+ Th1 cells, CD8+ cytotoxic T cells, Tregs, MDSCs, a<br /><br />]]></description>
<pubDate>Mon, 22 Jun 2026 10:35:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Can CD4 Antibody Become a Key Strategy for Improving Immune Reconstitution in HIV-Infected Individuals?]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10700</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif"><strong>1. Concept of CD4 Antibody and HIV-Mediated Immune Impairment</strong><br />
CD4 antibody is a specific immunoglobulin targeting the CD4 molecule, primarily expressed on CD4+ T lymphocytes&mdash;HIV&rsquo;s main target cells. HIV persistently attacks CD4+ T cells, causing their numerical decline and disrupting immune coordination. Even with virological suppression via antiviral therapy, some individuals experience incomplete immune re<br /><br />]]></description>
<pubDate>Mon, 22 Jun 2026 10:21:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Can FOXP3 Antibody Reveal New Mechanisms for Maintaining Regulatory T Cell Function?]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10699</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif"><strong>1. Concept of FOXP3 and Regulatory T Cells (Tregs)</strong><br />
Regulatory T cells (Tregs) are key regulators of immune homeostasis, traditionally thought to depend on the transcription factor FOXP3 for identity and suppressive function. FOXP3 was considered a &quot;master regulator&quot; with continuous expression deemed indispensable. However, recent research reveals FOXP3&rsquo;s functional requirement is spatiotemporally heterog<br /><br />]]></description>
<pubDate>Mon, 22 Jun 2026 10:03:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Specialised Imaging: Ultra-fast High Resolution Video Camera]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10698</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif">The&nbsp;Aurora&nbsp;is a&nbsp;new&nbsp;ultra-high-speed video camera&nbsp;from&nbsp;Specialised Imaging&nbsp;capable of recording at speeds up to 20 million images per second at full resolution.&nbsp;</span>
<div style="text-align: center;"><br />
<span style="font-family:arial,helvetica,sans-serif"><img alt="" src="/imgproduct/2026/2026062235064764.jpg" style="height:333px; width:500px" /></span></div>

<div style="text-align: center;"><<br /><br />]]></description>
<pubDate>Mon, 22 Jun 2026 09:46:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Optical Surfaces: Ultra-high Precision Optical Flats]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10697</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif">Optical Surfaces Ltd.&nbsp;is a leading supplier of&nbsp;ultra-high precision optical flats&nbsp;to research establishments and national standards laboratories worldwide.&nbsp;<br />
&nbsp;<br />
Using highly stable optical materials such as Zerodur&reg;, and benefiting from a thermally stable production environment, Optical Surfaces routinely achieves surface accuracies of better than &#654;/20 peak to valley and surface roughness of less t<br /><br />]]></description>
<pubDate>Thu, 18 Jun 2026 10:13:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Everest Medicines Enters into Exclusive Licensing Agreement with Dimerix]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10696</link>
<description><![CDATA[<div style="text-align: center;"><span style="font-family:arial,helvetica,sans-serif"><strong>Everest Medicines Enters into Exclusive Licensing Agreement with Dimerix for DMX-200 in Greater China, South Korea and Southeast Asia</strong></span></div>
<br />
<span style="font-family:arial,helvetica,sans-serif">HONG KONG, Jun 16, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK)announced that it has entered into an exclusive licensing agreement with Australia Dimerix Limited (&ldquo;Dimeri<br /><br />]]></description>
<pubDate>Wed, 17 Jun 2026 09:42:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Validated Monospecific Recombinant and Monoclonal Antibodies]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10695</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif">Amsbio&nbsp;has expanded its diverse range of&nbsp;recombinant and monoclonal antibodies&nbsp;to include over 10,000 new&nbsp;validated monospecific products&nbsp;in 15,000 formulations to support research in cancer, immunology, neuroscience, and signal transduction.<br />
<br />
Every antibody in the new catalogue has been subject to rigorous validation technologies to confirm that they selectively recognize their intended targets across ap<br /><br />]]></description>
<pubDate>Wed, 17 Jun 2026 09:35:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Biotech Fluidics: Non-invasive Real-time Liquid Flowmeters]]></title>
<link>http://www.bio-equip.cn/ensrc.asp?Id=10694</link>
<description><![CDATA[<span style="font-family:arial,helvetica,sans-serif">Biotech Fluidics offers a range of non-invasive flowmeters for real-time, non-invasive monitoring of liquid flow.<br />
&nbsp;<br />
Measuring liquid flow rate has traditionally been served by devices such as volumetric flow meters despite their significant limitations. Based upon the measurement principle of heat dispersion &ndash; Biotech Liquid Flow Meters offer unprecedented time resolution thereby providing new insights into flow variat<br /><br />]]></description>
<pubDate>Tue, 16 Jun 2026 09:43:00  GMT</pubDate>
</item>
</channel>
</rss>
